This scenario has been tested in tumor-bearing mice and cancer patients, indicating that CKM has unique potential for use in reprogramming the local TME, as it selectively induces CTL attractants (but not Treg attractants) in tumor tissue and acts preferentially on the tumor (but not normal tissue) [77]. Here, CKM is linked to neoplasm.